Tradestie Institutional Equity Comparison Engine
WGS vs CDNA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CDNA Overall Edge
CDNA Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CareDx, Inc. (CDNA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while WGS counters with relative strength in Valuation. Fundamentally, WGS trades at 40.6x Forward P/E with -13.7% operating margin (+5.4% YoY revenue) versus CDNA at 47.1x Forward P/E and 1.6% operating margin (+39.3% YoY). In options structure, WGS sits in BREAKDOWN (21st %ile IV; Dealer Gamma Walls on Pro) against CDNA sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
WGS
WGS 40.6x vs CDNA 47.1x Fwd P/E
Growth & Margin Winner
CDNA
Op Margin -13.7% vs 1.6% ยท YoY +5.4% vs +39.3%
Momentum & Technical Winner
CDNA
1Y -60.9% vs +364.5% ยท 52W Pos 14% vs 77%
Options & Structure Winner
CDNA
BREAKDOWN (21st %ile IV) vs CONSOLIDATION (18th %ile IV)
WGS
NASDAQ
GeneDx Holdings Corp. Class A Common Stock
Services-Health Services
$51.02
-2.58% 1D
Market Cap
$1.6B
1M Return
-19.79%
1Y Return
-60.86%
Forward P/E
40.6x
Unified AI Score
49.5 / 100
HOLD
Tech 33.0
Fund 53.0
Flow 70.0
Mom 60.0
CDNA
NASDAQ
CareDx, Inc.
Services-Medical Laboratories
$73.72
-5.34% 1D
Market Cap
$4.1B
1M Return
+15.19%
1Y Return
+364.52%
Forward P/E
47.1x
Unified AI Score
24.5 / 100
STRONG SELL
Tech 15.0
Fund 36.0
Flow 70.0
Mom 25.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
WGS -60.86%
CDNA +364.52%
Spread: +425.38 pp (CDNA Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | WGS Revenue | CDNA Revenue | WGS Op. Margin | CDNA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $80M | N/A | -20.3% | CDNA |
| FY2019 | $200M | $130M | -15.5% | -19.3% | WGS |
| FY2020 | $180M | $190M | -134.9% | -11.7% | CDNA |
| FY2021 | $210M | $300M | -210.3% | -10.0% | CDNA |
| FY2022 | $230M | $320M | -284.5% | -24.0% | CDNA |
| FY2023 | $200M | $280M | -89.2% | -72.5% | CDNA |
| FY2024 | $310M | $330M | -7.6% | 12.2% | CDNA |
| FY2025 | $430M | $380M | -3.1% | -8.1% | WGS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | WGS | CDNA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.6B | $4.1B | Larger Scale | CDNA |
| Trailing P/E Ratio Valuation | 38.8x | 32.9x | Lower Multiple | CDNA |
| Forward P/E Ratio Valuation | 40.6x | 47.1x | Lower Multiple | WGS |
| Revenue Growth (YoY) Growth | +5.4% | +39.3% | Higher Growth | CDNA |
| Operating Margin (TTM) Profitability | -13.7% | 1.6% | Higher Margin | CDNA |
| Net Profit Margin Profitability | -24.1% | 25.9% | Higher Margin | CDNA |
| Return on Equity (ROE) Capital Efficiency | -41.4% | 33.0% | Higher ROE | CDNA |
| 52-Week Range Position Momentum | 14% ($32โ$171) | 77% ($15โ$91) | Stronger Trend | CDNA |
| Beta / 30D Volatility Risk Regime | 1.74ฮฒ ยท 111% Vol | 1.21ฮฒ ยท 98% Vol | Lower Realized Risk | CDNA |
| Unified Institutional Score Composite Signal | 49.5 / 100 (HOLD) | 24.5 / 100 (STRONG SELL) | Higher Composite | WGS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full WGS vs CDNA Buy Guide
WGS
BREAKDOWN
96d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
21st %ile
IV Regime
Compressed (<25th %ile)
CDNA
CONSOLIDATION
30d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
18th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither WGS nor CDNA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.